| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |